Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bandelow

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Psychiatry Research|March 10, 2000
The use of the Panic and Agoraphobia Scale in a clinical trialB Bandelow, E Brunner, A Broocks, et al.
Pharmacopsychiatry|October 1, 1998
Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamineJ Sandmann, B Lörch, B Bandelow, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 5, 1998
Rebound insomnia after hypnotic withdrawal in insomniac outpatientsG Hajak, P Clarenbach, W Fischer, et al.
Fortschritte Der Medizin. Originalien|April 9, 2002
[Generalized anxiety disorders (GAD)--a neglected illness? Background und aims of the GAD-P study]H U Wittchen, M Linden, W Schwarzer, et al.
Pharmacopsychiatry|August 19, 2007
Improvement of quality of life in panic disorder with escitalopram, citalopram, or placeboB Bandelow, D J Stein, O T Dolberg, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Effects of hypnotics on sleep quality and daytime well-being. Data from a comparative multicentre study in outpatients with insomniaG Hajak, P Clarenbach, W Fischer, et al.
Current Pharmaceutical Design|December 17, 2008
Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorderD Wedekind, A Sprute, A Broocks, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 9, 1999
Application of a new statistical approach to evaluate a clinical trial with panic disorder patientsB Bandelow, E Brunner, D Beinroth, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 31, 2002
Separation anxiety and actual separation experiences during childhood in patients with panic disorderB Bandelow, G Alvarez Tichauer, C Späth, et al.
Psychopharmacology|July 4, 2001
Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjectsA Broocks, T Meyer, C H Gleiter, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Psychiatry Research|March 10, 2000
The use of the Panic and Agoraphobia Scale in a clinical trialB Bandelow, E Brunner, A Broocks, et al.
Pharmacopsychiatry|October 1, 1998
Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamineJ Sandmann, B Lörch, B Bandelow, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 5, 1998
Rebound insomnia after hypnotic withdrawal in insomniac outpatientsG Hajak, P Clarenbach, W Fischer, et al.
Fortschritte Der Medizin. Originalien|April 9, 2002
[Generalized anxiety disorders (GAD)--a neglected illness? Background und aims of the GAD-P study]H U Wittchen, M Linden, W Schwarzer, et al.
Pharmacopsychiatry|August 19, 2007
Improvement of quality of life in panic disorder with escitalopram, citalopram, or placeboB Bandelow, D J Stein, O T Dolberg, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Effects of hypnotics on sleep quality and daytime well-being. Data from a comparative multicentre study in outpatients with insomniaG Hajak, P Clarenbach, W Fischer, et al.
Current Pharmaceutical Design|December 17, 2008
Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorderD Wedekind, A Sprute, A Broocks, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 9, 1999
Application of a new statistical approach to evaluate a clinical trial with panic disorder patientsB Bandelow, E Brunner, D Beinroth, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 31, 2002
Separation anxiety and actual separation experiences during childhood in patients with panic disorderB Bandelow, G Alvarez Tichauer, C Späth, et al.
Psychopharmacology|July 4, 2001
Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjectsA Broocks, T Meyer, C H Gleiter, et al.
Pageof 8